Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,613,000 | 4,566,000 | 6,201,000 | 89,000 | 5,364,000 |
| Depreciation Amortization | 2,693,000 | 2,103,000 | 2,050,000 | 1,480,000 | 1,404,000 |
| Income taxes - deferred | -962,000 | -1,552,000 | -116,000 | -214,000 | -2,098,000 |
| Accounts receivable | 157,000 | -406,000 | 313,000 | -1,171,000 | -218,000 |
| Accounts payable and accrued liabilities | -347,000 | 226,000 | -118,000 | 80,000 | -61,000 |
| Other Working Capital | -2,303,000 | -1,763,000 | 489,000 | -1,638,000 | -798,000 |
| Other Operating Activity | 3,155,000 | 5,898,000 | 2,565,000 | 9,542,000 | 5,551,000 |
| Operating Cash Flow | $8,006,000 | $9,072,000 | $11,384,000 | $8,168,000 | $9,144,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -86,000 | 232,000 | -607,000 | 12,403,000 | -534,000 |
| PPE Investments | -585,000 | -728,000 | -579,000 | -650,000 | -825,000 |
| Net Acquisitions | -1,152,000 | -1,797,000 | -1,584,000 | -25,920,000 | -4,251,000 |
| Purchase Of Investment | -442,000 | -172,000 | -380,000 | -455,000 | -1,773,000 |
| Other Investing Activity | 0 | -1,000 | 19,000 | 7,000 | -434,000 |
| Investing Cash Flow | $-2,265,000 | $-2,466,000 | $-3,131,000 | $-14,615,000 | $-7,817,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,980,000 | N/A | N/A | 8,184,000 | 0 |
| Debt Repayment | -2,250,000 | -1,500,000 | -4,750,000 | -2,500,000 | -2,750,000 |
| Common Stock Issued | 232,000 | 309,000 | 169,000 | 256,000 | 209,000 |
| Common Stock Repurchased | -1,000,000 | -1,396,000 | -546,000 | -1,583,000 | -1,749,000 |
| Dividend Paid | -3,809,000 | -3,709,000 | -3,605,000 | -3,449,000 | -3,222,000 |
| Other Financing Activity | -278,000 | -173,000 | -145,000 | -138,000 | -122,000 |
| Financing Cash Flow | $-5,125,000 | $-6,469,000 | $-8,877,000 | $770,000 | $-7,634,000 |
| Exchange Rate Effect | 57,000 | -63,000 | -35,000 | 43,000 | -2,000 |
| Beginning Cash Position | 5,412,000 | 5,338,000 | 5,997,000 | 11,631,000 | 17,940,000 |
| End Cash Position | 6,085,000 | 5,412,000 | 5,338,000 | 5,997,000 | 11,631,000 |
| Net Cash Flow | $673,000 | $74,000 | $-659,000 | $-5,634,000 | $-6,309,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,006,000 | 9,072,000 | 11,384,000 | 8,168,000 | 9,144,000 |
| Capital Expenditure | -585,000 | -728,000 | -579,000 | -650,000 | -825,000 |
| Free Cash Flow | 7,421,000 | 8,344,000 | 10,805,000 | 7,518,000 | 8,319,000 |